CERO — CERo Therapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00- $4.75m
- $5.05m
Annual balance sheet for CERo Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 6.82 | 1.6 |
| Prepaid Expenses | ||
| Total Current Assets | 7.08 | 1.97 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 4.27 | 3.16 |
| Total Assets | 11.3 | 5.13 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 1.16 | 3.51 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 4.12 | 5.08 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 7.23 | 0.044 |
| Total Liabilities & Shareholders' Equity | 11.3 | 5.13 |
| Total Common Shares Outstanding |